Table 3. Factors associated with the progression of microbleeds.
Unadjusted HR (95% CI*) | P-value | |
---|---|---|
PPI use | 1.368 (0.321–5.831) | 0.672 |
Never use | 1 (References) | |
Intermediate use | 1.603 (0.176–14.637) | 0.676 |
Long term use | 3.473 (0.381–31.673) | 0.270 |
Age at initial imaging | 0.952 (0.872–1.038) | 0.265 |
Hypertension | 1.666 (0.397–6.983) | 0.581 |
Diabetes | 2.836 (0.018–45.283) | 0.371 |
Dyslipidemia | 0.804 (0.161–4.005) | 0.804 |
Previous stroke/TIA | 1.777 (0.356–8.867) | 0.910 |
Coronary heart disease | 1.128 (0.138–9.190) | 0.910 |
Use of antiplatelet agents | 1.430 (0.285–7.179) | 0.664 |
*Abbreviation: HR, hazard ratio; CI, confidence interval; PPI, proton pump inhibitor; MRI, magnetic resonance imaging; TIA, transient ischemia attack